BioRestorative Therapies (BRTX) Projected to Post Earnings on Wednesday

BioRestorative Therapies (NASDAQ:BRTX) is expected to be releasing its Q1 2025 earnings data before the market opens on Wednesday, May 14th. Analysts expect BioRestorative Therapies to post earnings of ($0.32) per share and revenue of $0.38 million for the quarter.

BioRestorative Therapies (NASDAQ:BRTX) last released its earnings results on Thursday, March 27th. The company reported ($0.20) earnings per share for the quarter, beating the consensus estimate of ($0.27) by $0.07. The company had revenue of $0.50 million for the quarter, compared to the consensus estimate of $0.48 million. BioRestorative Therapies had a negative return on equity of 98.49% and a negative net margin of 2,697.08%. On average, analysts expect BioRestorative Therapies to post $-1 EPS for the current fiscal year and $-1 EPS for the next fiscal year.

BioRestorative Therapies Stock Performance

NASDAQ BRTX opened at $1.80 on Monday. The company has a market capitalization of $13.51 million, a PE ratio of -1.18 and a beta of 77.73. The business’s fifty day moving average is $1.74 and its 200 day moving average is $1.75. BioRestorative Therapies has a fifty-two week low of $1.03 and a fifty-two week high of $2.55.

BioRestorative Therapies Company Profile

BioRestorative Therapies, Inc, a life sciences company, focuses on the development of regenerative medicine products and therapies using cell and tissue protocols primarily involving adult stem cells. The company's two core developmental programs relate to the treatment of disc/spine disease and metabolic disorders.